mums, dads , newbies should also be aware of massive potential upside when any msb indication is approved. And they are now sitting near 12 year low prices, with product approval expected by the company this year
. That hasn't been the case except for once before in 2020. Now having claimed they satisfied the FDA's request, they expect commercialisation this year.
Mums, dads, newbies should also know this stock has traded over $12 before, at a time where product approval was over a decade away, and people bought in on the promise it might deliver. Today's price is 10% of the high 10 years ago, difference being the company today believes approval is under 8 months away.
Mums, dads, newbies should also be aware that in order to make money on shares, one must buy in at a low price, and sell at a high price. One does not simply make money from buying on a high and selling on a low. That is how one looses money. Anyone suggesting its a good idea to sell at a low after buying higher, is suggesting to you its a good idea to loose money. Mums dads newbies need to be aware of people who suggest its a good idea to do this, and loose money.
mums, dads and newbies should also be aware the price today, as i mention is around 10% of the decade old high price, and close to 10 year resistance levels. That is to say it rarely falls below here looking at historical prices.
Mums, dads, newbies should also understand msb is a start up biotech. Biotechs take a long time to bring products to market after extensive human trials.They have royalty income from their extensive world wide patents. they have two unlicensed products , one of which is going for approval this year in the USA. But this is a biotech, not a mining company that just discovered high grade ore, it takes time.
lastly mums, dads, newbies should consider the company has 5 different indications we know it is currently targeting, or 5 redundant shots on goal if you like.
GvHG in children approval expected this year.
GvHD in adults trial commence once children approved.
Covid ARDS final trial
Chronic Heart Failure treatment
Chrons disease ( so far 100% remission in all patients) update due in May for more patients.
A little bit like a mining company, that has discovered 5 separate gold deposits on separate claims. They have submitted for mining approval for the smallest claim, but are now not far behind with 4 other claims.
Good luck, fingers crossed the update in May continues to demonstrate 100 % remission in Crohns patients. Would be a world first if it continues.... dare I say.. cured.
- Forums
- ASX - By Stock
- 2022 ... Get your popcorn out!
mums, dads , newbies should also be aware of massive potential...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B |
Open | High | Low | Value | Volume |
$1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5127 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.57 | 39613 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5127 | 1.565 |
3 | 15000 | 1.560 |
2 | 8950 | 1.545 |
3 | 52000 | 1.540 |
1 | 100000 | 1.525 |
Price($) | Vol. | No. |
---|---|---|
1.570 | 14365 | 2 |
1.580 | 57756 | 6 |
1.585 | 5500 | 1 |
1.590 | 3123 | 1 |
1.600 | 5000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online